VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma. Cancer Discov. 2018 07; 8(7):822-835.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Animals
Antineoplastic Agents, Immunological
Disease Models, Animal
Drug Resistance, Neoplasm
Humans
Immunotherapy
Lung Neoplasms
Male
Mice
Middle Aged
Mutation
Prognosis
Programmed Cell Death 1 Receptor
Proto-Oncogene Proteins p21(ras)
authors with profiles
VASSILIKI A PAPADIMITRAKOPOULOU
JEREMY J ERASMUS
IGNACIO IVAN WISTUBA
JOHN VICTOR HEYMACH
NEDA KALHOR
BRETT CARTER
FERDINANDOS SKOULIDIS